Effects of polyhexamethylene guanidine phosphate on human gingival fibroblasts

Authors

  • Anton Vitt Department of Dental Medicine, Division of Periodontology, Karolinska Institutet, Huddinge, Sweden; Department of Therapeutic Dentistry, Belarusian State Medical University, Minsk, Belarus
  • Veronica Slizen Department of Microbiology, Virology and Immunology, Belarusian State Medical University, Minsk, Belarus
  • Elisabeth A. Boström Department of Dental Medicine, Division of Periodontology, Karolinska Institutet, Huddinge, Sweden
  • Tülay Yucel-Lindberg Department of Dental Medicine, Division of Periodontology, Karolinska Institutet, Huddinge, Sweden
  • Anna Kats Department of Dental Medicine, Division of Periodontology, Karolinska Institutet, Huddinge, Sweden
  • Rachael V. Sugars Department of Dental Medicine, Division of Oral Facial Diagnostics and Surgery, Karolinska Institutet, Huddinge, Sweden
  • Anders Gustafsson Department of Dental Medicine, Division of Periodontology, Karolinska Institutet, Huddinge, Sweden
  • Kåre Buhlin Department of Dental Medicine, Division of Periodontology, Karolinska Institutet, Huddinge, Sweden

DOI:

https://doi.org/10.1080/00016357.2017.1350993

Keywords:

Periodontal disease, chlorhexidine, fibroblasts, prostaglandin E2, pro-inflammatory cytokines, matrix metalloproteinase

Abstract

Objective: Polyhexamethylene guanidine phosphate (PHMG-P) was compared to chlorhexidine (CHX) in order to determine potential cytotoxic and immune-modulatory effects on human gingival fibroblasts.

Materials and methods: Cytotoxic effects of PHMG-P and CHX on human gingival fibroblasts were assessed using cell viability assay at various time points and concentrations. The effects of PHMG-P and CHX on the secretion of prostaglandin (PG) E2, interleukin (IL)-6, IL-8 and matrix metalloproteinase (MMP)-1 by non-stimulated or IL-1β stimulated fibroblasts were evaluated by enzyme-linked immunosorbent assays.

Results: PHMG-P concentration 0.00009% led to the total loss of fibroblast viability within 24 h, whereas inhibition of fibroblast viability by CHX occurred at significantly higher concentrations of 0.0009% (p < .001). Short-term exposure to 0.005% PHMG-P led to loss of fibroblast viability after 5 min, whilst cells exposed to 0.005% CHX survived 30 min of treatment (p < .001). IL-1β stimulation induced an inflammatory response with a significant increase in the secretion of PGE2, IL-6, IL-8 and MMP-1. Treatment of IL-1β stimulated fibroblasts in combination with PHMG-P or CHX at concentrations of 0.000045 or 0.0.00009% resulted in significantly decreased PGE2, IL-6, IL-8 and MMP-1 levels. PHMG-P or CHX alone did not affect the baseline secretion of PGE2, IL-6, IL-8 or MMP-1 by gingival fibroblasts.

Conclusions: Cytotoxic effects on gingival fibroblasts were triggered by both PHMG-P and CHX at concentrations below those used in clinical practice. The tested antiseptics did not cause inflammation and reduced IL-1β-induced secretion of inflammatory mediators and collagenase by gingival fibroblasts, which suggests anti-inflammatory properties.

Downloads

Download data is not yet available.

Downloads

Published

2017-10-03